CompanyGraph
At a glance
- Depends onUpstream position: supplies 6 industries, depends on 0
- PositionOperating margin is -107.3%, lower than 95% of its Specialty Business Services peers (median 12.1%)
- FinancialsAltman Z-Score 1.09: distress zone
- Interpretations7 currently firing — 7
Sign in to view price data.
Sign inThe reported statements, read against the company's own industry.
Financials view
Market Capitalization
472.51MUSDvs all stocks (USD)
Revenue (TTM)
62.38MUSDvs all stocks (USD)
Profit Margin
-145.22%vs Specialty Business Services peers
Beta
2.58xvs all stocks
52-Week Change
7.58%vs all stocks
Market Capitalization
472.51MUSDvs all stocks (USD)
Enterprise Value
390.53MUSDvs all stocks (USD)
Forward P/E
-30.97xvs Specialty Business Services peers
Price to Sales (TTM)
7.58xvs Specialty Business Services peers
Price to Book (MRQ)
3.27xvs Specialty Business Services peers
Enterprise to Revenue
6.26xvs Specialty Business Services peers
Enterprise to EBITDA
-5.61xvs Specialty Business Services peers
Gross Margin
34.12%vs Specialty Business Services peers
Profit Margin
-145.22%vs Specialty Business Services peers
Operating Margin
-107.31%vs Specialty Business Services peers
Return on Assets (TTM)
-22.02%vs Specialty Business Services peers
Return on Equity (TTM)
-61.72%vs Specialty Business Services peers
Revenue (TTM)
62.38MUSDvs all stocks (USD)
Revenue per Share (TTM)
1.82USDUpdated Sep 28, 2026Quarterly Revenue Growth
-5.90%vs Specialty Business Services peers
Gross Profit (TTM)
23.64MUSDvs all stocks (USD)
EBITDA (TTM)
-69.59MUSDvs all stocks (USD)
Net Income (TTM)
-90.34MUSDvs all stocks (USD)
Quarterly Earnings Growth (YoY)
-24.41%vs Specialty Business Services peers
Operating Cash Flow (TTM)
-65.91MUSDvs all stocks (USD)
Levered Free Cash Flow (TTM)
-52.57MUSDvs all stocks (USD)
Trailing Annual Dividend Rate
0.00USDUpdated Sep 28, 2026Trailing Annual Dividend Yield
0.00%vs all stocks
Payout Ratio
0.00%vs Specialty Business Services peers
Revenue
71.55MUSDFY2025 · Dec 31, 2025Cost of Goods Sold
42.39MUSDFY2025 · Dec 31, 2025Gross Profit
29.16MUSDFY2025 · Dec 31, 2025Operating Income
-86.85MUSDvs all stocks (USD)
Pre-tax Income
54.92MUSDFY2025 · Dec 31, 2025Income Tax Expense
3.61MUSDFY2025 · Dec 31, 2025Net Income
51.30MUSDFY2025 · Dec 31, 2025EBIT
62.33MUSDFY2025 · Dec 31, 2025EBITDA (Income Statement)
-70.58MUSDFY2025 · Dec 31, 2025Research & Development
36.67MUSDFY2025 · Dec 31, 2025Selling, General & Administrative
79.34MUSDFY2025 · Dec 31, 2025Non-operating Interest Income
2.44MUSDFY2025 · Dec 31, 2025Non-operating Interest Expense
7.42MUSDFY2025 · Dec 31, 2025EPS (Basic)
1.66USDFY2025 · Dec 31, 2025EPS (Diluted)
1.49USDFY2025 · Dec 31, 2025Basic Shares Outstanding
30.91MSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
30.91MSharesFY2025 · Dec 31, 2025Net Income from Continuing Operations
51.30MUSDFY2025 · Dec 31, 2025Operating Cash Flow
71.26MUSDFY2025 · Dec 31, 2025Free Cash Flow
38.49MUSDFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
25.39MUSDFY2025 · Dec 31, 2025Income Tax Paid
997.00KUSDFY2025 · Dec 31, 2025Interest Paid
6.92MUSDFY2025 · Dec 31, 2025Starting Profit (CF Statement)
51.30MUSDFY2025 · Dec 31, 2025Depreciation & Amortization
15.49MUSDFY2025 · Dec 31, 2025Stock-based Compensation
18.70MUSDFY2025 · Dec 31, 2025Other Non-cash Items
-22.85MUSDFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
8.07MUSDFY2025 · Dec 31, 2025Change in Accounts Payable (CF)
1.61MUSDFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
-1.06MUSDFY2025 · Dec 31, 2025Capital Expenditures
-32.78MUSDFY2025 · Dec 31, 2025Net Acquisitions
238.95MUSDFY2025 · Dec 31, 2025Purchase of Investments
-120.48MUSDFY2025 · Dec 31, 2025Sale of Investments
65.50MUSDFY2025 · Dec 31, 2025Net Investing Cash Flow
151.19MUSDFY2025 · Dec 31, 2025Long-term Debt Payments
-114.83MUSDFY2025 · Dec 31, 2025Net Financing Cash Flow
-77.54MUSDFY2025 · Dec 31, 2025Shares Outstanding
39.11MSharesUpdated Sep 28, 2026Float Shares
33.94MSharesUpdated Sep 28, 2026Shares Short
3.73MSharesUpdated Sep 28, 2026Short Ratio
6.89daysvs all stocks
Short % of Shares Outstanding
10.20%vs all stocks
% Held by Insiders
6.04%vs all stocks
% Held by Institutions
66.25%vs all stocks
Total Cash (MRQ)
91.67MUSDvs all stocks (USD)
Total Cash per Share (MRQ)
2.34USDUpdated Sep 28, 2026Total Debt (MRQ)
9.69MUSDvs all stocks (USD)
Total Debt to Equity (MRQ)
0.0672xvs Specialty Business Services peers
Current Ratio (MRQ)
1.87xvs Specialty Business Services peers
Book Value per Share (MRQ)
3.69USDUpdated Sep 28, 2026Total Assets
210.99MUSDvs all stocks (USD)
Total Current Assets
93.77MUSDFY2025 · Dec 31, 2025Total Liabilities
98.06MUSDFY2025 · Dec 31, 2025Total Non-current Assets
117.22MUSDFY2025 · Dec 31, 2025Total Non-current Liabilities
25.77MUSDFY2025 · Dec 31, 2025Total Current Liabilities
72.29MUSDFY2025 · Dec 31, 2025Cash
18.45MUSDFY2025 · Dec 31, 2025Cash Equivalents
6.36MUSDFY2025 · Dec 31, 2025Cash & Cash Equivalents
24.81MUSDFY2025 · Dec 31, 2025Other Short-term Investments
56.97MUSDFY2025 · Dec 31, 2025Accounts Receivable
4.18MUSDFY2025 · Dec 31, 2025Accounts Payable
14.87MUSDFY2025 · Dec 31, 2025Short-term Debt
4.64MUSDFY2025 · Dec 31, 2025Deferred Revenue
35.16MUSDFY2025 · Dec 31, 2025Long-term Debt
8.76MUSDFY2025 · Dec 31, 2025Other Non-current Liabilities
2.70MUSDFY2025 · Dec 31, 2025Common Stock (Book)
3.00KUSDFY2025 · Dec 31, 2025Retained Earnings
-487.34MUSDFY2025 · Dec 31, 2025Total Shareholders' Equity
112.93MUSDvs all stocks (USD)
52-Week Low
6.60USDUpdated Sep 28, 202652-Week High
25.93USDUpdated Sep 28, 202652-Week Change
7.58%vs all stocks
Beta
2.58xvs all stocks
50-Day MA
12.52USDUpdated Sep 28, 2026200-Day MA
13.69USDUpdated Sep 28, 2026Avg 10-Day Volume
749.21KSharesUpdated Sep 28, 2026Avg 30-Day Volume
618.29KSharesUpdated Sep 28, 2026Diluted EPS (TTM)
-2.91USDUpdated Sep 28, 2026Other Income / Expense
146.75MUSDFY2025 · Dec 31, 20257 interpretations currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsHow does this company use capital?
Diagnostic
High ROE With Large Non-Operating Gap and Elevated-Margin-With-Deceleration
Return on equity reads high, with a large gap between pretax and operating income.
Reads
Cash-Flow Ratios Elevated
More of its sales turn into cash than in its industry, and less of that cash is consumed by reinvestment than at most of its peers.
Reads
FCF Ratios Elevated
Its free cash flow is large next to assets and equity, and more of its operating cash reaches it than in its industry.
Reads
Is this company growing?
Diagnostic
High R&D Share With Multi-Year Share-Count Growth and Elevated SBC
Heavy R&D and stock pay, with the share count growing across six years.
Reads
Where is this company structurally exposed?
Ulcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility Elevated
It sits well below its peak, and the fall has been both deep and long.
SBC-to-Net-Income Elevated, SBC-to-Revenue Elevated, And Diluted Share Count Growing (6Y CAGR)
Pay in shares is large next to its revenue and its profit, and the share count keeps rising.
Reads
Share Dilution
Its share count has grown over six years, with more waiting in options.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Peer Positioning
Operating margin is -107.3%, lower than 95% of its Specialty Business Services peers (median 12.1%)Significant
Operating margin: -1.07Industry median: 0.12Industry P5: -0.10Peers compared: 61.00
Profit margin is -145.2%, lower than 95% of its Specialty Business Services peers (median 8.4%)Significant
Profit margin: -1.45Industry median: 0.08Industry P5: -0.14Peers compared: 61.00
Return on equity is -61.7%, lower than 95% of its Specialty Business Services peers (median 9.5%)Significant
Return on equity: -0.62Industry median: 0.09Industry P5: -0.13Peers compared: 61.00
Return on assets is -22%, lower than 95% of its Specialty Business Services peers (median 5.4%)Significant
Return on assets: -0.22Industry median: 0.05Industry P5: -0.07Peers compared: 61.00
Structural Tensions
Looks liquid, but the distress score says otherwiseNotable
Current Ratio: 1.87Altman Z-Score: 1.09
Financial Health
Altman Z-Score 1.09: distress zoneCritical
Altman Z-Score: 1.09
Supply Chain
Upstream position: supplies 6 industries, depends on 0Notable
Outgoing: 6.00Incoming: 0.00
Companies that share the same coordination system — how they create, deliver, or capture value.
MHA Plc
Tier 1SenseMakingUnit ReplicationRuleFlow
Capita plc
Tier 1SenseMakingUnit ReplicationFlowProduction
BlackSky Technology Inc.
Tier 1SenseMakingUnit ReplicationFlowInterface
Knights Group Holdings plc
Tier 1SenseMakingUnit ReplicationRuleFlow
RELX plc
Tier 1SenseMakingUnit ReplicationInterfaceFlow
XPS Pensions Group plc
Tier 2SenseMakingUnit ReplicationRuleInterface
H&R Block Inc.
Tier 2SenseMakingUnit ReplicationInterfaceRule
Wolters Kluwer N.V.
Tier 2SenseMakingUnit ReplicationRuleInterface
Thomson Reuters Corporation
Tier 2SenseMakingUnit ReplicationRuleInterface
Hefei Taihe Intelligent Technology Co., Ltd.
Tier 3SenseMakingThroughput-Bound ConversionInterfaceProduction
Companies that share active interpretations — structural patterns currently present in both stocks.
Palladyne AI Corp
4 interpretationsHigh R&D Share With Multi-Year Share-Count Growth and Elevated SBCUlcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility ElevatedSBC-to-Net-Income Elevated, SBC-to-Revenue Elevated, And Diluted Share Count Growing (6Y CAGR)Share Dilution
Perella Weinberg Partners
4 interpretationsFCF Ratios ElevatedCash-Flow Ratios ElevatedSBC-to-Net-Income Elevated, SBC-to-Revenue Elevated, And Diluted Share Count Growing (6Y CAGR)Share Dilution
Abeona Therapeutics Inc.
4 interpretationsHigh R&D Share With Multi-Year Share-Count Growth and Elevated SBCFCF Ratios ElevatedCash-Flow Ratios ElevatedHigh ROE With Large Non-Operating Gap and Elevated-Margin-With-Deceleration